- Androgen receptor antagonists: a patent review (2008-2011)
[作者:Mohler, ML; Coss, CC; Duke, CB; Patil, SA; Miller, DD; Dalton, JT,期刊:Expert Opinion on Therapeutic Patents, 页码:541-565 , 文章类型: Review,,卷期:2012年22-5]
- Introduction: Androgen receptor (AR) antagonists are predominantly used as chemical castration to treat prostate cancer (i.e., in conjunction with androgen deprivation therapy (ADT)). Unfortunately, castration-resistant ...
|